Intuitive Surgical (NASDAQ:ISRG – Get Free Report) had its target price dropped by equities researchers at Truist Financial from $666.00 to $605.00 in a report issued on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the medical equipment provider’s stock. Truist Financial’s price target would suggest a potential upside of 24.89% from the stock’s current price.
ISRG has been the topic of several other research reports. Jefferies Financial Group increased their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Leerink Partners raised their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Raymond James raised their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. JPMorgan Chase & Co. increased their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Finally, Citigroup raised their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a report on Friday, January 24th. One analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $610.19.
Check Out Our Latest Stock Report on Intuitive Surgical
Intuitive Surgical Trading Up 1.6 %
Insiders Place Their Bets
In other news, EVP Brian Edward Miller sold 8,900 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the transaction, the executive vice president now directly owns 5,758 shares of the company’s stock, valued at $2,793,033.06. The trade was a 60.72 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the transaction, the executive vice president now directly owns 5,224 shares of the company’s stock, valued at approximately $2,607,925.28. This trade represents a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 33,754 shares of company stock valued at $17,691,621. 0.90% of the stock is owned by insiders.
Institutional Investors Weigh In On Intuitive Surgical
Institutional investors have recently added to or reduced their stakes in the stock. M.E. Allison & CO. Inc. acquired a new stake in Intuitive Surgical in the 4th quarter valued at $449,000. Seilern Investment Management Ltd acquired a new stake in Intuitive Surgical in the 4th quarter valued at $82,517,000. Sycomore Asset Management grew its stake in Intuitive Surgical by 27.4% in the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock valued at $9,214,000 after acquiring an additional 4,079 shares during the period. Exome Asset Management LLC grew its stake in Intuitive Surgical by 16.8% in the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after acquiring an additional 1,069 shares during the period. Finally, China Universal Asset Management Co. Ltd. grew its stake in Intuitive Surgical by 5.6% in the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock valued at $5,138,000 after acquiring an additional 525 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Recommended Stories
- Five stocks we like better than Intuitive Surgical
- With Risk Tolerance, One Size Does Not Fit All
- Disney Stock: 4 Key Metrics Validating Its Comeback
- Growth Stocks: What They Are, What They Are Not
- Resilient Investing: 3 Stocks Built to Weather Market Volatility
- How to Use the MarketBeat Dividend Calculator
- Gold Breaks $3,000: What’s Driving the Rally and How to Invest?
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.